Funded Tech Companies

Hemab Therapeutics

Wondering who backed Hemab Therapeutics? Invus, Access Biotechnology and Rock Springs Capital joined the equity holders in this biopharmaceutical company.

Company Overview

Contact Information

Company Background Information

Overview

Hemab Therapeutics ApS is an emerging biotech company supported by Novo Holdings A/S with the aim of developing novel treatments for rare and underserved bleeding disorders. Based in Copenhagen, the company is led by a team of drug developers and scientists with deep expertise in haemophilia. Hemab has exclusive licences to state-of-the-art antibody technologies from both Novo Nordisk A/S and Genmab A/S.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

2/21/2023

Financing History

Management Team

Title

Name

Email & Social

Chief Executive Officer

Benny Sorensen

        

Chief Financial Officer

Mads Behrndt?

        

Chief Technical Officer

Johan Faber

        

Company Investors

• Invus
• Access Biotechnology
• Rock Springs Capital
• Healthcap Venture Capital
• Deep Track Capital
• Maj Invest
• Avoro Ventures
• RA Capital
• Novo Holdings

Browse more funded tech companies:

Helu | Hemanext

Share this article

About Our Venture Capital Database

The company data above is provided by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary